Thursday, October 15, 2009

Security lapse at on October 15, 2009 at entrance to Harrison Plaza shopping center in Malate, Manila. Because of said security lapse, I could have brought
deadly weapons into said area, to the detriment of shoppers.

On October 15, 2009, ShopWise store at Harrison Plaza sold an imported food product which did not bear a visible (to unaided eye) name and address of the
importer of said product. I believe said store violated the Consumer Act of the Philippines.
__________________________________________________________________________________________________________________________________________________________

Meditation and Health
http://www.cdc.gov/Features/Meditation/

Tell your health care providers about any complementary and alternative practices you use. Give them a full picture of what you do to manage your health. Do not use meditation as a replacement for conventional care or as a reason to postpone seeing a doctor about a medical problem.

Many people practice meditation for a number of health-related purposes. A 2007 national government survey found that 9.4% of respondents had used meditation in the past 12 months.
Photo: People meditating.What is meditation?

The term meditation refers to a group of techniques which may be practiced for many reasons, such as to increase calmness and physical relaxation, to improve psychological balance, to cope with illness, or to enhance overall wellness. Most types of meditation have four elements in common:

A quiet location. Meditation is usually practiced in a quiet place with as few distractions as possible. This can be particularly helpful for beginners.

A specific, comfortable posture. Depending on the type being practiced, meditation can be done while sitting, lying down, standing, walking, or in other positions.

A focus of attention. Focusing one's attention is usually a part of meditation. For example, the meditator may focus on a mantra (a specially chosen word or set of words), an object, or the sensations of the breath.

An open attitude. Having an open attitude during meditation means letting distractions come and go naturally without judging them.
How can meditation affect my health?

It is not fully known what changes occur in the body during meditation; whether they influence health; and, if so, how. Research is under way to find out more about meditation's effects, how it works, and diseases and conditions for which it may be most helpful.

The National Center for Complementary and Alternative Medicine (NCCAM) is the federal government's lead agency for scientific research on complementary and alternative medicine (CAM). It is 1 of the 27 institutes and centers that make up the National Institutes of Health within the U.S. Department of Health and Human Services. Some recent NCCAM-supported studies have been investigating meditation for relieving stress in caregivers for elderly patients with dementia and for relieving asthma symptoms. A study published in the April 2009 issue of Preventing Chronic Disease researched use of meditation and other complementary and alternative practices in patients suffering from arthritis. See full article.
Is meditation right for me?

Meditation is considered to be safe for healthy people but if you are thinking about using meditation practices to prevent asthma attacks, to control high blood pressure, to reduce arthritis pain, or for any other medical reason, be smart.

* Do not use meditation as a replacement for conventional care or as a reason to postpone seeing a doctor about a medical problem.
* Look for published research studies on meditation for the health condition in which you are interested.
* Tell your health care providers about any complementary and alternative practices you use. Give them a full picture of what you do to manage your health. This will help ensure coordinated and safe care.
_______________________________________________________________________________________________________________________________________________________________________________________________________________
Recent Consumer Updates
http://www.fda.gov/ForConsumers/ConsumerUpdates/default.htm
* Reducing Radiation from Medical X-rays (video)
* Cooperative Program Ensures Safe Shellfish (slideshow)
* Cooperative Programs Help Keep Food Safe
* Cooperative Program Ensures Safe Shellfish
* FDA's MedWatch Safety Alerts: September 2009
* Avoiding Medication Mistakes (video)
* Fortify Your Knowledge About Vitamins (video)


FDA NEWS RELEASE

For Immediate Release: Oct. 13, 2009

Media Inquiries: Chris Kelly, 301-796-4676, christopher.kelly@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA
FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets
Four Companies Required to Stop Making and Distributing Illegal Opioid Pain Relievers
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm186418.htm

The U.S. Food and Drug Administration today warned four companies that they must stop marketing unapproved codeine sulfate tablets. These drugs are opioid analgesics, commonly called narcotics, that are widely used to treat pain.

These particular products have not received FDA approval and the agency has no evidence that they are safe and effective. Another manufacturer, Roxane Laboratories, markets FDA-approved codeine sulfate tablets and is able to meet the demand for the drug. The FDA does not anticipate a supply problem for codeine sulfate tablets.

“Consumers deserve and expect that their drugs meet modern FDA standards for safety, effectiveness, labeling, and quality. Removing unapproved products that do not meet those standards is an FDA priority,” said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research (CDER). “The FDA urges drug companies to ensure all drugs they make and market have appropriate FDA approval.”

The names of the products and the manufacturers and distributors that received the warning letters are:

* Codeine Sulfate Tablets, 30 mg, 60 mg – Lehigh Valley Technologies Inc., Allentown, Penn.
* Codeine Sulfate Tablets, 30 mg, 60 mg – Cerovene Inc., Valley Cottage, N.Y.
* Codeine Sulfate Tablets, 30 mg – Dava International Inc., Fort Lee, N.J.
* Codeine Sulfate Tablets, 30 mg, 60 mg – Glenmark Generics Inc. USA, Mahwah, N.J.

Companies receiving the warning letters have 15 days to give the FDA a plan to discontinue marketing the unapproved drugs. Manufacturers have 90 days to cease manufacturing of new product, and distributors have 180 days to cease further shipment of existing products. Previously manufactured unapproved products may still be found on pharmacy shelves for a period of time.

Today's action is part of the FDA's initiative against the marketing of unapproved drugs, announced in June 2006. At that time, the agency published a Compliance Policy Guide describing the FDA's risk-based enforcement approach to unapproved products.

“Doctors and patients often find that some drugs on the market do not have FDA approval,” said Deborah M. Autor, director of CDER's Office of Compliance. “This lack of approval undermines the FDA's process to ensure that safe and effective drugs are available to the U.S. public.”

Consumers who rely on opioid analgesics for pain relief have access to products that have been evaluated by the FDA and determined to be safe and effective for use. There are other FDA-approved drugs, including different opioid analgesics, which can be used to relieve pain. Consumers should consult a health care professional for detailed guidance on treatment options.

For additional information, including copies of the warning letters that identify the firms involved and the names of their products, see the FDA's Unapproved Drugs Web page/Enforcement Actions.

___________________________________________________________________________________________________________________________________________________________________________________________________________

musipedia org web site
http://www.musipedia.org/



snagfilms com web site
http://www.snagfilms.com/

No comments:

image of registry return receipt of letter addressed to Makati councilor J. J. Binay

image of registry return receipt of letter addressed to Makati councilor J. J. Binay